FDA Approved: ISTODAX — Original Application (Celgene Corporation)

View source ↗

Summary

The FDA granted original approval for ISTODAX (romidepsin) to Celgene. The approval covered treatment for cutaneous T-cell lymphoma, including mycosis fungoides…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides
• Sézary Syndrome

Drugs mentioned

• Istodax (romidepsin)

Snippet

ORIG AP for ISTODAX (ROMIDEPSIN)